Cue Biopharma Ownership | Who Owns Cue Biopharma?


OverviewForecastRevenueFinancialsChartTranscripts

Cue Biopharma Ownership Summary


Cue Biopharma is owned by 22.90% institutional investors, 0.55% insiders, and 76.54% retail investors. Bleichroeder lp is the largest institutional shareholder, holding 9.75% of CUE shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 2.38% of its assets in Cue Biopharma shares.

CUE Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockCue Biopharma22.90%0.55%76.54%
SectorHealthcare Stocks 57.39%9.93%32.68%
IndustryBiotech Stocks 68.48%9.65%21.87%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Bleichroeder lp5.00M9.75%$5.45M
Vanguard group2.06M4.01%$2.24M
Blackrock756.74K1.53%$938.35K
Blackrock funding, inc. /de638.95K1.25%$696.46K
Geode capital management631.28K1.23%$688.25K
Robertson stephens wealth management478.50K0.93%$521.57K
Sigma planning447.18K0.87%$487.42K
Good life advisors400.00K0.78%$436.00K
Northern trust350.42K0.71%$434.52K
Advisory research257.23K0.50%$280.38K

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Bleichroeder lp5.00M1.37%$5.45M
Advisory research257.23K0.05%$280.38K
Good life advisors400.00K0.03%$436.00K
Robertson stephens wealth management478.50K0.02%$521.57K
Sigma planning447.18K0.02%$487.42K
Gsa capital partners llp149.80K0.01%$163.00K
Point72 asia (singapore) pte.27.76K0.01%$30.26K
Xtx topco46.97K0.00%$51.20K
Texas capital bank wealth management services33.10K0.00%$36.08K
Seacrest wealth management13.00K0.00%$14.17K

Top Buyers

HolderShares% AssetsChange
Geode capital management631.28K0.00%122.45K
Blackrock funding, inc. /de638.95K-67.98K
Hrt financial lp49.05K0.00%49.05K
Sigma planning447.18K0.02%45.85K
Hightower advisors128.28K0.00%45.00K

Top Sellers

HolderShares% AssetsChange
Slate path capital lp---2.40M
Blackrock756.74K--1.49M
Millennium management69.30K--289.68K
Renaissance---274.03K
Monaco asset management sam---253.19K

New Positions

HolderShares% AssetsChangeValue
Texas capital bank wealth management services33.10K0.00%33.10K$36.08K
Virtu financial16.83K0.00%16.83K$18.00K
Golden state wealth management2.00K0.00%2.00K$2.18K
Macquarie group1.80K-1.80K$2.24K
Physician wealth advisors1.01K0.00%1.01K$1.10K

Sold Out

HolderChange
Assetmark-2.00
Nelson, van denburg & campbell wealth management group-7.00
Farther finance advisors-43.00
Innealta capital-49.00
Srs capital advisors-215.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Dec 31, 2024555.77%11,733,877-15.65%223.11%30150.00%6-64.71%
Sep 30, 202451-32.00%13,910,2910.71%273.48%13-61.76%17-15.00%
Jun 30, 202475-5.06%13,812,235-15.72%272.18%3447.83%20-28.57%
Mar 31, 202479-7.06%16,389,05610.09%353.47%23-37.84%2847.37%
Dec 31, 2023857.59%14,886,6376.22%323.28%378.82%1918.75%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
Vanguard Total Stock Mkt Idx Inv1.51M2.38%81.86K
Vanguard US Total Market Shares ETF1.35M2.18%-1.00
Vanguard Institutional Extnd Mkt Idx Tr673.06K1.06%2.24K
Fidelity Extended Market Index346.87K0.56%-2.21K
iShares Micro-Cap ETF110.05K0.18%-
Fidelity Total Market Index108.58K0.18%-87.00
NT R2000 Growth Index Fund - NL103.76K0.17%-
BlackRock Extended Equity Market K103.23K0.17%-44.00
Extended Equity Market Fund K102.14K0.17%313.00
NT R2000 Index Fund - NL89.94K0.15%-9.65K

Recent Insider Transactions


DateNameRoleActivityValue
Dec 16, 2024PASSERI DANIEL R CHIEF EXECUTIVE OFFICERBuy$30.90K
Aug 25, 2023Suri Anish PRESIDENT AND CSOBuy$11.04K
Aug 14, 2023PASSERI DANIEL R CHIEF EXECUTIVE OFFICERBuy$8.58K
Mar 23, 2023Kiener Peter A-Sell$30.59K
May 27, 2022Morich Frank Buy$105.00K

Insider Transactions Trends


DateBuySell
2025 Q1--
2024 Q41-
2024 Q3--
2024 Q2--
2024 Q1--

CUE Ownership FAQ


Who Owns Cue Biopharma?

Cue Biopharma shareholders are primarily institutional investors at 22.90%, followed by 0.55% insiders and 76.55% retail investors. The average institutional ownership in Cue Biopharma's industry, Biotech Stocks , is 68.48%, which Cue Biopharma falls below.

Who owns the most shares of Cue Biopharma?

Cue Biopharma’s largest shareholders are Bleichroeder lp (5M shares, 9.75%), Vanguard group (2.06M shares, 4.01%), and Blackrock (756.74K shares, 1.53%). Together, they hold 15.30% of Cue Biopharma’s total shares outstanding.

Does Blackrock own Cue Biopharma?

Yes, BlackRock owns 1.53% of Cue Biopharma, totaling 756.74K shares as of Jun 2024. This represents 0% of BlackRock's total assets, with a market value of 938.35K$. In the last quarter, BlackRock decreased its holdings by -1.487M shares, a -66.28% change.

Who is Cue Biopharma’s biggest shareholder by percentage of total assets invested?

Bleichroeder lp is Cue Biopharma’s biggest shareholder by percentage of total assets invested, with 1.37% of its assets in 5M Cue Biopharma shares, valued at 5.45M$.

Who is the top mutual fund holder of Cue Biopharma shares?

Vanguard Total Stock Mkt Idx Inv is the top mutual fund holder of Cue Biopharma shares, with 2.38% of its total shares outstanding invested in 1.51M Cue Biopharma shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools